The Annual General Meeting of
Adoption of financial statements and discharge from liability
The Annual General Meeting adopted the financial statements for the financial year of 2023 and discharged the members of the Board of Directors and the CEO from liability.
Use of the profit shown on the balance sheet and the payment of dividend
The Annual General Meeting resolved in accordance with the proposal of the Board of Directors that no dividend be paid based on the balance sheet adopted for the financial year ended
Members and remuneration of the Board of Directors
The number of the members of the Board of Directors was confirmed to be six (6).
The annual remuneration of the Chair and members of the Board of Directors shall remain unchanged and therefore the Chair of the Board shall be paid an annual remuneration of
The committee members shall be paid
Election and remuneration of the Auditor
The Auditor’s fees will be paid against the Auditor’s reasonable invoice approved by the Company.
Authorizing the Board of Directors to decide on the repurchase and/or on the acceptance as pledge of the Company’s own shares
The Board of Directors was authorized to decide on the repurchase and/or on the acceptance as pledge of the Company’s own shares. The authorization covers a maximum of 1,435,414 shares, which corresponds to approximately 10 percent of all shares in the Company. Only the unrestricted equity of the Company can be used to repurchase own shares on the basis of the authorization.
Own shares can be repurchased at a price formed in public trading on the date of the repurchase or otherwise at a price formed on the market. The Board of Directors decides how own shares will be repurchased and/or accepted as pledge. Shares can be repurchased using, among other things, derivatives. Own shares can be repurchased otherwise than in proportion to the shareholdings of the existing shareholders (directed repurchase).
The authorization allows the repurchase and/or the acceptance as pledge of shares in order to, among other things, develop the Company’s capital structure, to finance or implement eventual acquisitions, investments or other arrangements that are part of the business, or to be used in the Company’s incentive or reward systems.
The authorization is effective until the end of the next Annual General Meeting; however, no longer than until
Authorizing the Board of Directors to decide on the issuance of shares and the issuance of special rights entitling to shares
The Board of Directors was authorized to decide on the issuance of shares and other special rights entitling to shares referred to in Chapter 10, Section 1 of the Finnish Limited Liability Companies Act. The authorization covers a maximum of 1,435,414 shares, which corresponds to approximately 10 percent of all shares in the Company.
The Board of Directors decides on all terms of the issuance of shares and of special rights entitling to shares. The issuance of shares and of special rights entitling to shares may be carried out in deviation from the shareholders’ pre-emptive rights (directed issue).
The authorization is effective until the end of the next Annual General Meeting; however, no longer than until
The minutes of the Annual General Meeting
The minutes of the Annual General Meeting will be available on the Company’s website at www.administergroup.com/en/investors/ on
The organising meeting of the Board of Directors
In its organising meeting, the Board of Directors of the Company has elected
The Board of Directors has elected
Administer Plc
The Board of Directors
Further information
CEO
Tel. +358 50 560 6322
kimmo.herranen@administer.fi
Certified Adviser:
About Administer Oyj
www.administergroup.com
Attachments
- Download announcement as PDF.pdf
© STT Info Finland, source